ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American Academy of Child and Adolescent Psychiatry

• Publication date

  2005-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/01.CHI.0000173291.28688.E7PMID 16175106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

  2006cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Effects of Once-Daily Osmotic-Release Methylphenidate on Blood Pressure and Heart Rate in Children with Attention-Deficit/Hyperactivity Disorder: Results from a One-Year Follow-up Study

  2004cited by this paper
• Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

  2004cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

  2004cited by this paper
• PSYCHIATRIC DIAGNOSIS IN PRESCHOOL CHILDREN

  2003cited by this paper
• ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.

  2003cited by this paper
• Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.

  2003cited by this paper
• A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

  2002cited by this paper
• How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.

  2001cited by this paper
• Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

  2001cited by this paper
• Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Short-term cardiovascular effects of methylphenidate and adderall.

  2001cited by this paper
• Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.

  2000cited by this paper
• The stimulants revisited.

  2000cited by this paper
• The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder.

  1999cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• Attention-deficit/hyperactivity disorder: a life-span perspective.

  1998cited by this paper
• Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry.

  1997cited by this paper
• Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• Methylphenidate dosing: twice daily versus three times daily.

  1996cited by this paper
• Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children.

  1989cited by this paper
• How do Hyperactive Children Feel About Taking Stimulants and Will They Tell the Doctor?

  1982cited by this paper
• Growth of hyperactive children treated with methylphenidate.

  1979cited by this paper
• Hyperactive children. A continuous long-term placebo-controlled follow-up.

  1974cited by this paper
• Hyperactive children. A continuous long-term placebo-controlled follow-up.

  1974cited by this paper

• Pharmacological management for insomnia in children and adolescents with autism and attention deficit and hyperactivity disorder

  2025cites this paper
• Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial

  2023cites this paper
• Methylphenidate remediates aberrant brain network dynamics in children with attention-deficit/hyperactivity disorder: A randomized controlled trial

  2022cites this paper
• Monitor growth changes from central nervous system stimulants in patients with attention-deficit/hyperactivity disorder

  2022cites this paper
• Methylphenidate Enhances Spontaneous Fluctuations in Reward and Cognitive Control Networks in Children With Attention-Deficit/Hyperactivity Disorder.

  2022influential citation
• Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD

  2021cites this paper
• Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents

  2021cites this paper
• Sleep Variables as Predictors of Treatment Effectiveness and Side Effects of Stimulant Medication in Newly Diagnosed Children with Attention-Deficit/Hyperactivity Disorder.

  2020cites this paper
• Methylphenidate in children with monogenic obesity due to LEPR or MC4R deficiency improves feeling of satiety and reduces BMI‐SDS—A case series

  2020cites this paper
• Frequency and individual severity of arterial blood pressure changes in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate hydrochloride: a prospective non-interventional study

  2020cites this paper
• Seizure risk, methylphenidate, and ADHD: reassuring news.

  2020cites this paper
• Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis.

  2020cites this paper
• ADHD Medications and Sleep

  2019cites this paper
• Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.

  2019cites this paper
• Title: Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence

  2019cites this paper
• Child & adolescent mental health

  2018cites this paper
• Methylphenidate and Reduced Overweight in Children With ADHD

  2018cites this paper
• Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis#

  2018influential citation
• What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research

  2018cites this paper
• Stimulant Withdrawal in a Child with Autism Spectrum Disorder and ADHD - A Case Report.

  2018cites this paper
• Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

  2018cites this paper
• The safety of extended-release drug formulations for the treatment of ADHD

  2017cites this paper
• Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD

  2017cites this paper
• Attention Deficit Hyperactivity Disorder in Appalachia: proposed methods to analyze and solve social and medical issues surrounding the disorder

  2017cites this paper
• “Holy Psychotherapy, Batman!” Diagnosing Mental Illness in Superheroes

  2017cites this paper
• Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

  2017cites this paper
• IMPACT OF SLEEP ON DAYTIME FUNCTIONING AND RESPONSE TO TREATMENT IN CHILDREN WITH ADHD

  2017influential citation
• Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder

  2016cites this paper
• ADHD and the Disruptive Behavior Disorders

  2016cites this paper
• Caught in the eye of the storm: a qualitative study of views and experiences of planned drug holidays from methylphenidate in child and adolescent ADHD treatment.

  2016cites this paper
• Dampak Metilfenidat Kerja Panjang 20 Mg Terhadap Pola Perbaikan Gejala Klinis pada Anak dengan Gangguan Pemusatan Perhatian/Hiperaktivitas (GPPH)

  2016cites this paper
• Safety and Tolerability of Medications for ADHD

  2016cites this paper
• When ADHD and substance use disorders coexist : etiology and pharmacological treatment

  2015cites this paper
• Exercise outcomes in prevalent users of stimulant medications.

  2015cites this paper
• Examining why patients with attention-deficit/hyperactivity disorder lack adherence to medication over the long term: a review and analysis.

  2015cites this paper
• Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe

  2015cites this paper
• Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?

  2015cites this paper
• Drug Holidays From ADHD Medication

  2015influential citation
• Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?

  2015cites this paper
• Caloric and nutrient intake in children with attention deficit hyperactivity disorder treated with extended-release methylphenidate: analysis of a cross-sectional nutrition survey

  2014cites this paper
• Premarket Safety and Efficacy Studies for ADHD Medications in Children

  2014cites this paper
• Safety of medicines used for ADHD in children: a review of published prospective clinical trials

  2014cites this paper
• A Review of OROS Methylphenidate (Concerta®) in the Treatment of Attention-Deficit/Hyperactivity Disorder

  2014influential citation
• The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial

  2014cites this paper
• [Dietary patterns in patients with attention deficit hyperactivity disorder].

  2014cites this paper
• TDAH infantil y metilfenidato : predictores clínicos de respuesta al tratamiento

  2014cites this paper
• Modelo dietético en pacientes con déficit de atención e hiperactividad

  2014cites this paper
• ADHD in a Double-Blind Placebo-Controlled Trial The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With

  2013cites this paper
• A study att ention defic it hyperactivity disorder and medical treatment among adolescent males

  2013cites this paper
• Metylofenidat (Medikinet) w leczeniu zespołu ADHD – opinie lekarzy na podstawie badania metodą delficką

  2013cites this paper
• Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies

  2013cites this paper
• VENTRAL TEGMENTAL AREA NEURONAL RESPONSES TO METHYLPHENIDATE CORRELATED TO BEHAVIORAL RESPONSES OF ADOLESCENT AND ADULT RATS

  2013influential citation
• Neurofunctional Markers of Reward and Timing Processing in Adult Attention Deficit and Hyperactiviy Disorder: an fMRI Study

  2013cites this paper
• Behavioral responses to methylphenidate: correlations with neuronal activity in the caudate nucleus

  2013cites this paper
• Effects of Osmotic-Release Methylphenidate on Height and Weight in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Following up to Four Years of Treatment

  2012cites this paper
• Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.

  2012cites this paper
• Attention-Deficit Hyperactivity Disorder

  2012cites this paper
• Effect of 12-Week Administration of 20-mg Long-Acting Methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr Ratios in the Prefrontal Cortices of School-Age Children in Indonesia: A Study Using 1H Magnetic Resonance Spectroscopy (MRS)

  2012cites this paper
• Health Care Guideline Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents

  2012cites this paper
• Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder

  2012cites this paper
• Nutrición y trastorno por déficit de atención/hiperactividad:: seguimiento evolutivo de las variables antropométricas de un grupo de pacientes en tratamiento con metilfenidato de liberación osmótica

  2011cites this paper
• Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

  2011influential citation
• Medicatie bij ADHD : een analyse van klassiek gebruikte stimulantia & atomoxetine

  2011influential citation
• [Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate].

  2011cites this paper
• Pharmacokinetics and Therapeutic Effect of OROS® Methylphenidate Under Different Breakfast Conditions in Children with Attention-Deficit/Hyperactivity Disorder

  2011cites this paper
• Pharmacological treatment of ADHD and the short and long term effects on sleep.

  2011cites this paper
• Does 20 mg long-acting methylphenidate alter blood pressure and heart rate in children with ADHD?

  2011cites this paper
• Nutrición y trastorno por déficit de atención/hiperactividad: seguimiento evolutivo de las variables antropométricas de un grupo de pacientes en tratamiento con metilfenidato de liberación osmótica

  2011cites this paper
• Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Titration, 1-Year Study

  2011cites this paper
• Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

  2011cites this paper
• Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.

  2011cites this paper
• Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries

  2010cites this paper
• Oros Methylphenidate in the Treatment of Adults with Adhd: A 6-Month, Open-Label, Follow-Up Study

  2010cites this paper
• Attention deficit hyperactivity disorder in adults

  2010cites this paper
• CAPÍTULO 19 – TRATAMIENTO FARMACOLÓGICO DEL TDAH Y LAS COMORBILIDADES

  2010cites this paper
• Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

  2010cites this paper
• The Side Effects and Correlates of OROS-Methylphenidate in the Treatment of Children and Adolescents with ADHD.

  2010cites this paper
• Plasma Methylphenidate Concentrations in Youths Treated with High-Dose Osmotic Release Oral System Formulation

  2010cites this paper
• 35 – Psychopharmacological Management of Children and Adolescents

  2010cites this paper
• Dose–Response Characteristics in Adolescents with Attention-Deficit/Hyperactivity Disorder Treated with OROS® Methylphenidate in a 4-Week, Open-Label, Dose-Titration Study

  2010cites this paper
• The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorder

  2010influential citation
• A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin® LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting

  2010cites this paper
• Dopamine-Related Genotypes and the Dose–Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths

  2009cites this paper
• Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.

  2009cites this paper
• ADHD psychopharmacology across the lifespan

  2009influential citation
• Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment

  2009cites this paper
• Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation Study

  2009cites this paper
• [Drugs for attention deficit hyperactivity disorder].

  2009cites this paper
• Safety of stimulant treatment in attention deficit hyperactivity disorder: part I

  2009cites this paper
• Drug treatments for attention-deficit hyperactivity disorder in young people

  2009cites this paper
• Safety of stimulant treatment in attention deficit hyperactivity disorder: part II

  2009cites this paper
• Capítulo 11 – Trastorno por déficit de atención

  2009cites this paper
• Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial

  2009cites this paper
• Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants

  2009cites this paper
• South African educators’ experiences of learners who may have ADHD in their classrooms

  2009cites this paper
• Disruptive Behavior Disorders

  2008cites this paper
• Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHD

  2008cites this paper
• Long-term safety of stimulant medications used to treat children with ADHD.

  2008cites this paper
• [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations].

  2008cites this paper
• Constantes vitales en niños expuestos a metilfenidato

  2008cites this paper